Gujarat Terce Laboratories Quarterly Results for Trading Insights
GUJTERC • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹0 Cr
QSept 2021
Gujarat Terce Laboratories Quarterly Results Key Highlights
- Revenue of ₹10 Cr in Sept 2021 (+0.0% vs Jun 2021, +42.9% vs Sept 2020)
- EBITDA of ₹1 Cr in Sept 2021 (-50.0% vs Jun 2021)
- Operating Margin of 5.0% in Sept 2021 (-11.0pp vs Jun 2021)
- Earnings Per Share of ₹0.61 in Sept 2021 (-71.8% vs Jun 2021)
Gujarat Terce Laboratories Quarterly Results Analysis
| Metric | Sept 2021 | Jun 2021 | Sept 2020 | Mar 2020 | Jun 2020 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 10 | 10 | 7 | 10 | 5 | - | 42.9% |
| Net Profit (₹ Cr) | 0 | 2 | 0 | -1 | 0 | - | - |
| EBITDA (₹ Cr) | 1 | 2 | 0 | 0 | 0 | - | - |
| EPS (₹) | 0.61 | 2.16 | -0.02 | 0.00 | -0.60 | - | - |
| Operating Margin (%) | 5.0% | 16.0% | 2.0% | -5.0% | -8.0% | - | - |
Gujarat Terce Laboratories Share Price Trend Around Quarterly Results
Visualize Gujarat Terce Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Gujarat Terce Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Gujarat Terce Laboratories
Additional stock information and data for GUJTERC
Revenue Trend (₹ Cr)
Mar 2020
10
Sept 2020
7
Jun 2021
10
Sept 2021
10
Net Profit Trend (₹ Cr)
Mar 2020
-1
Sept 2020
0
Jun 2021
2
Sept 2021
0
Operating Margin Trend (%)
Mar 2020
-5.0%
Sept 2020
2.0%
Jun 2021
16.0%
Sept 2021
5.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Gujarat Terce Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹438,094.57 Cr | 1812.8 | 14,875 | 3,125 | +10.8% | - | 21.0% | 139.4 |
|
Divis Laboratories
Sept 2025 |
₹167,616.86 Cr | 6372.0 | 2,860 | 689 | +7.1% | - | 24.1% | 245.4 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹148,025.88 Cr | 4427.8 | 3,219 | 591 | +11.3% | - | 18.4% | 252.4 |
|
Dr Reddys Laborator…
Sept 2025 |
₹110,630.25 Cr | 1314.6 | 9,135 | 1,337 | +1.1% | - | 14.6% | 81.2 |
|
Cipla
Sept 2025 |
₹107,029.80 Cr | 1333.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.7 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores